Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hoepner

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
CNS Neuroscience & Therapeutics|November 10, 2018
Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional studyAndrei Miclea, Anke Salmen, Greta Zoehner, et al.
Journal of Central Nervous System Disease|May 31, 2022
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19Lara Diem, Livia Fregolente-Gomes, Jan D Warncke, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 8, 2022
CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid CellsKirsten Guse, Nina Hagemann, Lisa Thiele, et al.
Scientific Reports|October 25, 2022
Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosisRobert Hoepner, Stephanie Rodgers, Katharina Stegmayer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 14, 2022
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune EncephalomyelitisJana Remlinger, Adrian Madarasz, Kirsten Guse, et al.
Therapeutic Advances in Neurological Disorders|October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease courseGreta Zoehner, Andrei Miclea, Anke Salmen, et al.
Journal of Neuroinflammation|January 10, 2020
Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosisLisa Thiele Née Schrewe, Kirsten Guse, Silvia Tietz, et al.
CNS Neuroscience & Therapeutics|October 13, 2020
Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohortKrenar Veselaj, Nicole Kamber, Myriam Briner, et al.
Multiple Sclerosis and Related Disorders|August 22, 2025
Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC scoreGabriel Bsteh, Vincenzo Introcaso, Christiane Gradl, et al.
Journal of Neurology|January 27, 2016
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective studyIlya Ayzenberg, Joanna Schöllhammer, Robert Hoepner, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
CNS Neuroscience & Therapeutics|November 10, 2018
Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional studyAndrei Miclea, Anke Salmen, Greta Zoehner, et al.
Journal of Central Nervous System Disease|May 31, 2022
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19Lara Diem, Livia Fregolente-Gomes, Jan D Warncke, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 8, 2022
CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid CellsKirsten Guse, Nina Hagemann, Lisa Thiele, et al.
Scientific Reports|October 25, 2022
Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosisRobert Hoepner, Stephanie Rodgers, Katharina Stegmayer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 14, 2022
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune EncephalomyelitisJana Remlinger, Adrian Madarasz, Kirsten Guse, et al.
Therapeutic Advances in Neurological Disorders|October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease courseGreta Zoehner, Andrei Miclea, Anke Salmen, et al.
Journal of Neuroinflammation|January 10, 2020
Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosisLisa Thiele Née Schrewe, Kirsten Guse, Silvia Tietz, et al.
CNS Neuroscience & Therapeutics|October 13, 2020
Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohortKrenar Veselaj, Nicole Kamber, Myriam Briner, et al.
Multiple Sclerosis and Related Disorders|August 22, 2025
Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC scoreGabriel Bsteh, Vincenzo Introcaso, Christiane Gradl, et al.
Journal of Neurology|January 27, 2016
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective studyIlya Ayzenberg, Joanna Schöllhammer, Robert Hoepner, et al.
Pageof 13